NCT07019116

Brief Summary

In Rio Grande do Sul, Brazil, the demand for specialty care referrals has increased sharply with the adoption of the electronic regulatory system, especially in rural areas. In 2023 alone, over 79,000 referrals were submitted monthly, totaling 1.7 million annual gatekeeping decisions. Due to workforce limitations, nearly 70% of referrals are authorized automatically, often without clinical validation. This leads to delays for high-risk patients, unnecessary specialist visits, and a growing backlog, currently over 172,000 pending referrals. To address this, an AI algorithm was developed to triage referrals based on urgency and appropriateness. The investigators propose a prospective controlled study with randomized implementation of the AI tool across selected specialty queues in the electronic referral system. The population will consist of referrals from specialties waitlists from municipalities in Rio Grande do Sul. Specialties to be included will be selected by the State Health Department prospectively according to gatekeeping needs. The intervention will be an AI-based triage algorithm. The control will be a standard gatekeeping process. The primary outcome is the proportion of referrals with a final decision (authorized or redirected to primary care) within six months; secondary outcomes include time to decision and appointment, system-level performance metrics. Referrals will be randomly assigned to algorithmic or human gatekeeping with a 1:1 ratio. The algorithm classifies referrals into two groups: not authorized (pending more data or teleconsultation), authorized. Authorization cases are further divided into routine and high-risk referrals to help the manage demand. Each AI prediction provides a probability from 0 to 1 of authorization (or deferring). The implementation threshold is set at 0.8; cases below this level will be classified as low confidence for decision and will not be included. According to the State Health Department's decisions, several referral lines are expected to be selected for the intervention. A sample size 934 (467 per arm) for each included specialty was calculated to detect a 1.2 relative risk for the primary outcome with 90% power and 5% significance.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
934

participants targeted

Target at P75+ for not_applicable

Timeline
43mo left

Started Nov 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Nov 2025Dec 2029

First Submitted

Initial submission to the registry

June 5, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 13, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

November 15, 2025

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

February 20, 2026

Status Verified

February 1, 2026

Enrollment Period

3 years

First QC Date

June 5, 2025

Last Update Submit

February 19, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Referrals with final decision

    The proportion of referrals with a final decision includes those authorized for specialist care and those redirected to primary care without an in-person specialist consultation.

    6 months

Secondary Outcomes (4)

  • Time to final decision

    6 months

  • Time to consult in high-risk patients

    6 months

  • Use of remote consultations

    6 months

  • Waitlist size over time

    6 months

Study Arms (2)

Standard gatekeeping process

ACTIVE COMPARATOR

In standard gatekeeping, the current process will be used without interventions.

Other: Standard gatekeepingOther: Subsequent interactions between primary care and regulation system

Artificial Intelligence for Gatekeeping

EXPERIMENTAL

An AI algorithm will perform the first evaluation (triaging) of the referral.

Other: AI algorithmOther: Subsequent interactions between primary care and regulation system

Interventions

Human evaluators (mostly physicians) review referrals and determine, based on established protocols, whether they should be authorized.

Standard gatekeeping process

An AI algorithm was developed to perform the first evaluation (triaging) of the referrals inserted in the electronic referral system from the Rio Grande do Sul Health Department.

Artificial Intelligence for Gatekeeping

After the first evaluation of a referral, several subsequent rounds of interaction between gatekeepers and primary care physicians can be conducted to further detail patient needs and urgency.

Artificial Intelligence for GatekeepingStandard gatekeeping process

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All referrals from a given specialty (waitlist) will be eligible.
  • Specialties will be selected following Rio Grande do Sul Health Department priorities.

You may not qualify if:

  • Referrals that the AI algorithm can not evaluate. These include referrals with attachments (further information in image or PDF files) and referrals with previous rounds of discussion.
  • Referrals in which the algorithm has low confidence in the decision (i.e., informed data lead to a decision with a probability below 80%) will not be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Central de Regulação Ambulatorial

Porto Alegre, Rio Grande do Sul, Brazil

RECRUITING

Study Officials

  • Dimitris V. Rados, Ph.D.

    TelessaúdeRS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dimitris V Rados, Ph.D.

CONTACT

Natan Katz, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2025

First Posted

June 13, 2025

Study Start

November 15, 2025

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2029

Last Updated

February 20, 2026

Record last verified: 2026-02

Locations